---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-21-066698"
form_type: "8-K"
ticker: "AMST"
cik: "0001807166"
company_name: "Amesite Inc."
filed_at: "2021-12-21T23:59:59+00:00"
generated_at: "2026-06-27T23:24:32.690702+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Amesite terminates CFO Matthew Kern, appoints Mark Corrao as CFO effective Dec 15, 2021

## Summary
- Matthew Kern terminated as CFO on Dec 15, 2021; Mark Corrao appointed same day.
- Corrao serves as non-employee, part-time CFO; compensation $3,000 signing + $3,000/month.
- Corrao is also CFO of Neuropathix and former CFO of Generex Biotechnology and Brain Scientific.
- Agreement includes indemnification and D&O insurance; term is one year, extendable by mutual consent.
- Corrao remains independent CFO; company also retains The CFO Squad LLC for pre-audit and SEC compliance.

## SEC filing metadata
- accession: 0001213900-21-066698
- form_type: 8-K
- ticker: AMST
- cik: 0001807166
- company_name: Amesite Inc.
- filed_at: 2021-12-21T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1807166/000121390021066698/0001213900-21-066698-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1807166/000121390021066698/ea152831-8k_amesite.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-21-066698
- JSON: https://secwatch.observer/filing/0001213900-21-066698.json
- Plain text: https://secwatch.observer/filing/0001213900-21-066698.txt

## Key facts
- Executive change
  Matthew Kern was terminated as Chief Financial Officer at Amesite Inc..
  - Action: terminated
  - Role: Chief Financial Officer
  source text: On December 15, 2021 (the “Effective Date”), the board of directors (the “Board”) of Amesite Inc. (the “Company”) authorized and approved the termination of Matthew Kern as Chief Financial Officer of the Company, effective as of the Effective Date.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1807166/000121390021066698/0001213900-21-066698-index.htm
- Executive change
  Mark Corrao was appointed as Chief Financial Officer at Amesite Inc..
  - Action: appointed
  - Role: Chief Financial Officer
  source text: In addition, on December 15, 2021, in connection with the termination of Mr. Kern, the Board authorized and approved the appointment of Mark Corrao, age 64, as Chief Financial Officer of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1807166/000121390021066698/0001213900-21-066698-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.